Pages that link to "Q43720035"

The following pages link to Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features. (Q43720035):

Displaying 23 items.

• Reciprocal translocation (3;5)(q26;q22) and possible BCHE gene involvement in an unusual myelogenous disorder with both myeloproliferative and dysplastic features (Q33334992) (← links)
• The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes (Q33407572) (← links)
• Pediatric hyperfibrotic myelodysplasia: an unusual clinicopathologic entity (Q33498861) (← links)
• Acute panmyelosis with myelofibrosis (Q34322728) (← links)
• Myelodysplasia with fibrosis: a distinct entity? (Q34353334) (← links)
• Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis. (Q34543049) (← links)
• Myelodysplastic syndrome associated with bone marrow fibrosis (Q35664744) (← links)
• Myelodysplastic syndrome with myelofibrosis transformed to a precursor B-cell acute lymphoblastic leukemia: a case report with review of the literature (Q36169249) (← links)
• Early Improvement in Marrow Fibrosis Following Haploidentical Stem Cell Transplantation for a Patient with Myelodysplastic Syndrome with Bone Marrow Fibrosis (Q37521161) (← links)
• Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells (Q38719813) (← links)
• FAB classification of myelodysplastic syndromes: merits and controversies (Q40458883) (← links)
• Treatment and prognostic factors in myelodysplastic syndromes (Q40948240) (← links)
• Special cytological subtypes of acute myeloid leukaemias and myelodysplastic syndromes (Q41055073) (← links)
• TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis (Q41572334) (← links)
• The diagnostic and prognostic value of bone marrow immunostaining in myelodysplastic syndromes (Q41727858) (← links)
• Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis. (Q46330963) (← links)
• Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems. (Q53100468) (← links)
• Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes. (Q53225234) (← links)
• Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes (Q70597339) (← links)
• Prognostic factors in idiopathic (Primary) osteomyelofibrosis (Q73605917) (← links)
• 5q- syndrome presenting chronic myeloproliferative disorders-like manifestation: a case report (Q73801255) (← links)
• Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis (Q80406124) (← links)
• Myelofibrosis in primary myelodysplastic syndromes: clinical and biological significance (Q81097068) (← links)